Sarepta Therapeutics Inc (NASDAQ:SRPT)

75.97
Delayed Data
As of 4:00pm ET
 +0.29 / +0.38%
Today’s Change
61.28
Today|||52-Week Range
101.24
-15.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.3M5.4M154.6M301.0M
 
 
 
 
 
Cost of Goods Sold--130.0K314.0K22.8M
 
 
 
 
Depreciation And Amortization5.2M5.6M8.1M12.2M
 
 
 
 
 
 
Operating ExpensesGross Income---320.0K146.2M266.0M
 
 
 
 
General Expenses207.0M261.8M282.8M607.9M
 
 
 
 
 
Research And Development146.4M186.3M166.5M397.9M
 
 
 
 
 
Total Operating Expenses212.3M267.6M291.2M643.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-211.0M-262.2M-136.7M-342.0M
 
 
 
 
 
Extraordinary Credit0.000.00125.0M2.2M
 
 
 
Extraordinary Charge-9.2M-4.6M-35.0M-6.2M
 
 
 
 
 
Interest Expense On Debt--535.0K5.8M33.7M
 
 
 
 
Other Expenses0.000.002.0M1.7M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-220.0M-267.3M-48.6M-362.6M
 
 
 
 
 
Income Taxes0.000.00-2.1M-692.0K
 
 
 
Net Income-220.0M-267.3M-50.7M-361.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.3M48.7M58.8M66.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.3M48.7M58.8M66.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.20-$5.49-$0.86-$5.46
 
 
 
 
 
EPS Diluted-$5.20-$5.49-$0.86-$5.46